Skip to contentI
Intelligent Bio Solutions Inc.
I
INBSIntelligent Bio Solutions Inc. Q1 2025 · 10-Q
Revenue$872.29K$872.29K+9.6% vs Q1 2024 Net Income-$2.69M-$2.69MN/M vs Q1 2024 EPS Diluted-$0.70-$0.70N/M vs Q1 2024 Gross Profit$346,801+49.3% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Intelligent Bio Solutions Inc. · CIK 1725430 · Engraved from SEC EDGAR
Operating Cash Flow-$2,387,216N/M Margins · derivedGross margin39.8%+10.6 pt vs Q1 2024
Operating margin-312.4%+4.9 pt vs Q1 2024
Net margin-307.9%−3.2 pt vs Q1 2024
ended Sep 30, 2024 · filed Nov 7, 2024 · 38 d after period end